Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2023-04-04 Transaction in Own Shar…
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
关于股份回购实施结果的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from Shenzhen Huitai Medical Equipment Co., Ltd. regarding the results of a share repurchase program. It details the approval, implementation, and completion of the share buyback, including the number of shares repurchased, prices, and the intended use of the repurchased shares. It also discloses insider trading activity during the repurchase period. The document is not a full financial report but a specific announcement about the company's transaction in its own shares. Therefore, it fits the category of 'Transaction in Own Shares' (POS). The document length is 1874 characters, which is consistent with an announcement rather than a full report.
2023-04-04 Chinese
关于以集中竞价交易方式回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase (buyback) activity. It details the number of shares repurchased, prices, total funds used, and references the company's board approval and regulatory compliance. The document length is short (1305 characters) and it provides specific transactional data about the company's own shares being bought back. This matches the definition of a Transaction in Own Shares (POS) filing, which reports on share repurchase activities. It is not an announcement of a report, nor a full financial report, but a specific update on share buyback progress.
2023-03-02 Chinese
2022年度业绩快报
Earnings Release Classification · 95% confidence The document is titled as a "2022 年度业绩快报公告" which translates to "2022 Annual Performance Express Report Announcement." It contains preliminary financial data for the year 2022, including revenue, profit, net income, earnings per share, and asset information. The data is explicitly stated as preliminary and unaudited, with a note that the final audited data will be in the 2022 Annual Report. The document is relatively short (2429 characters) and serves as a quick earnings update rather than a full annual report. This matches the characteristics of an Earnings Release (ER), which provides initial key financial highlights for a fiscal period. It is not a full Annual Report (10-K) or Interim Report (IR) because it lacks comprehensive financial statements and detailed analysis. It is also not a Report Publication Announcement (RPA) because it contains substantive financial data, not just a notice of report availability. FY 2022
2023-02-23 Chinese
关于变更签字注册会计师的公告
Audit Report / Information Classification · 95% confidence The document is an announcement from Shenzhen Huitai Medical Device Co., Ltd. regarding the change of the signing certified public accountant for the 2022 annual audit. It details the replacement of the project partner and signing CPA due to rotation and independence requirements. The document does not contain the audit report itself or financial data but is a notice about the change in auditors. It is a standalone announcement related to audit information but not the audit report itself. Therefore, it fits best under Audit Report / Information (AR) category, which covers standalone audit reports and related announcements excluding full annual reports. The document length is short (1459 characters), and it is not a report publication announcement or certification letter. Hence, classification as AR is appropriate with high confidence. FY 2022
2023-02-08 Chinese
关于以集中竞价交易方式回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase (buyback) activity. It details the number of shares repurchased, prices, total funds used, and references the company's board approval and regulatory compliance. The document length is short (1305 characters) and it provides specific transactional data about the company's own shares being bought back. This matches the definition of a Transaction in Own Shares (POS) filing, which reports on share repurchase activities. It is not an announcement of a report or a regulatory filing, but a direct update on the share buyback progress.
2023-02-01 Chinese
2022年年度业绩预告
Regulatory Filings Classification · 95% confidence The document is titled as a 2022 annual performance forecast (业绩预告) for Shenzhen Huitai Medical Devices Co., Ltd. It provides preliminary estimated financial results for the full year 2022, including net profit and adjusted net profit, with comparisons to the prior year. It explicitly states that the forecast is unaudited and that the final accurate financial data will be disclosed in the formal 2022 annual report. The document is short (1006 characters) and serves as a performance forecast announcement rather than a full annual report or earnings release. It does not contain full financial statements or detailed analysis, only preliminary estimates. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement of forecasted financial results, not the actual report or earnings release itself.
2023-01-19 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.